The first half of 2021 might be when vaccine could be available, says the leading professor of the team of scientists at Imperial College London, who are working to develop the COVID-19 vaccine.
The second human trial of the vaccine has already begun in the UK. With 300 volunteers and the first few volunteers have been receiving doses of the vaccine. The first trial is reported to be successful as the volunteer seems to be healthy since injected on 19th June.
The Trails and Tests
The university is working long hours to develop a publicly available vaccine with the help of Oxford University’s Jenner Institute.
Imperials aim to distribute the vaccine abroad next year. That too if the trial is successful among the 6,000 volunteers, which is planned to begin in October.
Professor Robin Shattock says that through their clinical trials they are now ready to fight the virus. After devoting an exhaustive 6 months to chase the vaccine. He added that his team has been sharing data with the professors of Oxford University.
On Tuesday, he also told a Royal Society of Medicine webinar, ‘It does seem like we are contested against each other. But we are collaboratively working and trading resources to enhance the hunt of vaccine’.
An RNA vaccine was developed by the team of Professor Shattock. It sends genetic commands to the body’s cells to produce the “spike” protein spotted on the surface of corona virus.
The Covid-19 Vaccine
Tendering protection against Covid-19, the existence of this protein triggers an immune reaction. To produce a set of an RNA serum, not one virus is required, making it safer to construct. Only a minor volume of a virus is utilized for gene sequencing and vaccine testing.
For any vaccine to be clinically approved, it requires strong data that will be available at the start of 2021 says, Professor Shattock. The data will be will vigorous enough to be approved.
He also stated, ‘We truly need to deal with facts and data rather than over-promising and under-delivering. For now, there is a lot of speculation.’
The Professor’s team collected a further £18.5 million pounds from the government past month. And is progressing to depend on public support for the research of vaccines.
Although the vaccine will not be able to provide ‘full’ safety from the corona virus but will surely decrease the intensity of the illness.
Oxford University’s Jenner Institute has temporarily participated in a private-public collaboration with a multinational pharmaceutical company ‘AstraZeneca’ to hasten the advancement of its vaccine.
The university said Imperial and VGH will ignore payments for the UK. And low-income countries and charge only modest. Cost-plus prices to sustain the enterprise’s work, quicken worldwide delivery, and backing new research.